Orange Book product · Brand (NDA)
AVANDARYL
GLIMEPIRIDE; ROSIGLITAZONE MALEATE
At a glance
Nov 23, 2005
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 23, 2005
20 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
GLIMEPIRIDE; ROSIGLITAZONE MALEATE
Strength
1MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 021700
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
